Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Merck KGaA : Effect Pigments for Architecture: Merck Exhibits at the Middle East Coatings Show 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/05/2012 | 10:24am CET

Darmstadt/Germany, March 5, 2012 - Merck will be presenting its effect pigments for architecture at the Middle East Coatings Show in Dubai from March 12 to 14, 2012. This exhibition is the most important platform for the coatings sector in the Middle East and the Gulf region. The focus of the exhibition will be on architectural applications, which have been seeing rapid growth in the region for the past several years. The trend toward gold and silver shades, which can currently be seen in lifestyle products and interior designs, is also being reflected in architecture.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERCK KGAA
02/16 MERCK : New Hypertension Findings from Merck KGaA Described [Management of Hyper..
02/16 MERCK : North American Businesses of Merck KGaA, Darmstadt, Germany Certified as..
02/15 MERCK : to Supply Single-Use Systems to WuXi Biologics for Non-GMP Pilot Plant i..
02/09 Verastem Announces Dosing of First Patient in Combination Trial of Defactinib..
02/09 MERCK : North American Businesses of Merck KGaA, Darmstadt, Germany Certified as..
02/09 MERCK : Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with ..
02/07 MERCK : Jaffrey biochemical company to pay fine by EPA after alleged water pollu..
02/07 MERCK : Millipore settles lawsuit with EPA
02/07 MERCK : Jaffrey firm to pay penalty and comply with Clean Water Act
02/06 MERCK : Jaffrey, N.H. Facility to Upgrade Its Wastewater Treatment Systems Under..
More news
Sector news : Specialty & Advanced Pharmaceuticals
11:51aDJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
10:23aDJPURETECH HEALTH : Appoints Atul Pande as Chief Medical Officer
08:49aDJBAYER : Financing Plan Will Raise Equity First Then Bonds -- WSJ
08:49aDJBAYER : CEO Still Upbeat on Deal -- WSJ
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
More sector news : Specialty & Advanced Pharmaceuticals
News from SeekingAlpha
02/03 Pfizer May Be Another IBM
01/23 Merck KGaA teams up with Domain Therapeutics in immuno-oncology
01/18 Astra's Mystic Mystery And Other Surprises In Store
01/12 Vertex And German Merck Find Their Perfect Fit
01/12 JPMorgan Day Three Roundup - Trump Reminds The Sector Who's In Charge
Advertisement
Financials (€)
Sales 2016 15 060 M
EBIT 2016 3 447 M
Net income 2016 1 795 M
Debt 2016 11 019 M
Yield 2016 1,19%
P/E ratio 2016 24,29
P/E ratio 2017 23,19
EV / Sales 2016 1,62x
EV / Sales 2017 1,44x
Capitalization 13 312 M
More Financials
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 109 €
Spread / Average Target 5,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA3.88%14 053
ABBVIE INC-1.26%97 803
KYOWA HAKKO KIRIN CO L..4.26%8 585
JAZZ PHARMACEUTICALS P..24.67%8 082
MALLINCKRODT PLC8.61%5 675
ZHANGZHOU PIENTZEHUANG..0.79%4 177
More Results